Latest return on equity
Entrada Therapeutics Return on equity
Entrada Therapeutics (TRDA) return on equity with its verified observation date.
Direct answer
Entrada Therapeutics's return on equity is -54.1%.
The verified market snapshot reports -54.1%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 20, 2026.
Get free Entrada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -54.1%
Explore related company data
View Entrada Therapeutics's market capitalizationView Entrada Therapeutics's price-to-book ratioView Entrada Therapeutics's 52-week price rangeView Entrada Therapeutics's revenue growthView Entrada Therapeutics's profit marginView Entrada Therapeutics's debt-to-equity ratioView all Entrada Therapeutics key metricsReturn to Entrada Therapeutics profile